1. Home
  2. CGEN vs SFBC Comparison

CGEN vs SFBC Comparison

Compare CGEN & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • SFBC
  • Stock Information
  • Founded
  • CGEN 1993
  • SFBC 1953
  • Country
  • CGEN Israel
  • SFBC United States
  • Employees
  • CGEN N/A
  • SFBC N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • SFBC Savings Institutions
  • Sector
  • CGEN Health Care
  • SFBC Finance
  • Exchange
  • CGEN Nasdaq
  • SFBC Nasdaq
  • Market Cap
  • CGEN 149.6M
  • SFBC 127.6M
  • IPO Year
  • CGEN 2000
  • SFBC N/A
  • Fundamental
  • Price
  • CGEN $1.56
  • SFBC $51.30
  • Analyst Decision
  • CGEN Strong Buy
  • SFBC
  • Analyst Count
  • CGEN 1
  • SFBC 0
  • Target Price
  • CGEN $4.00
  • SFBC N/A
  • AVG Volume (30 Days)
  • CGEN 299.7K
  • SFBC 1.6K
  • Earning Date
  • CGEN 03-04-2025
  • SFBC 04-28-2025
  • Dividend Yield
  • CGEN N/A
  • SFBC 1.49%
  • EPS Growth
  • CGEN N/A
  • SFBC N/A
  • EPS
  • CGEN N/A
  • SFBC 1.80
  • Revenue
  • CGEN $27,864,000.00
  • SFBC $35,777,000.00
  • Revenue This Year
  • CGEN $22.94
  • SFBC N/A
  • Revenue Next Year
  • CGEN $15.88
  • SFBC N/A
  • P/E Ratio
  • CGEN N/A
  • SFBC $28.33
  • Revenue Growth
  • CGEN N/A
  • SFBC N/A
  • 52 Week Low
  • CGEN $1.35
  • SFBC $39.15
  • 52 Week High
  • CGEN $2.66
  • SFBC $55.99
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 38.91
  • SFBC 52.49
  • Support Level
  • CGEN $1.54
  • SFBC $50.22
  • Resistance Level
  • CGEN $1.64
  • SFBC $51.99
  • Average True Range (ATR)
  • CGEN 0.08
  • SFBC 0.63
  • MACD
  • CGEN 0.01
  • SFBC 0.20
  • Stochastic Oscillator
  • CGEN 26.92
  • SFBC 78.50

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

Share on Social Networks: